US Patent and Trademark Office data show a slowing of NIH-supported cancer patent innovation since 1995, amid criticism of an incremental rather than a high-risk, high-reward funding strategy.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kolata, G. Grant system leads cancer researchers to play it safe. The New York Times (27 June 2009).
Drazen, J. M. & Ingelfinger, J. R. N. Engl. J. Med. 349, 2259–2261 (2003).
Fang, F. C. & Casadevall, A. MBio 7, e00422–16 (2016).
Nicholson, J. M. & Ioannidis, J. P. A. Nature 492, 34–36 (2012).
Salzberg, S. L. Nature 493, 26 (2013).
Mervis, J. Science 338, 1274 (2012).
President’s Council of Advisors on Science and Technology. Transformation and Opportunity: The Future of the US Research Enterprise. https://orise.orau.gov/cdc/documents/pcast-future-research-enterprise.pdf (2012).
Frumkin, J. & Myers, A. USPTO Cancer Moonshot patent data. https://developer.uspto.gov/product/cancer-moonshot-patent-data (19 August 2016).
Chartrand, S. Patents: a coming court test on whether corn seed and mathematical instructions have similar status. The New York Times (12 March 2001).
Lawrence, S. Nat. Biotechnol. 22, 930–931 (2004).
USPTO. Utility examination guidelines (USPTO, 2001).
Trajtenberg, M. Rand J. Econ. 21, 172–187 (1990).
Acknowledgements
The author thanks S. Bechtold, B. Sampat, L. Wier and the participants of the American Society of Law, Medicine & Ethics bioip Faculty Workshop, Atlanta, and the Inaugural Wiet Life Science Law Scholars Conference, Chicago, for comments and suggestions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Zingg, R. The declining impact of the US National Institutes of Health on cancer patenting. Nat Biotechnol 37, 722–723 (2019). https://doi.org/10.1038/s41587-019-0165-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-019-0165-4